W. A. Richards

Clinical Psychology · 2008–2016

A researcher in the Science corpus: 3 papers; trusts 3 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

• Clinical Psychology — 15 citations into it; #2,163 of 8,024 by trust here, #2,366 by citations
• Health — 7 citations into it; #1,144 of 2,035 by trust here, #811 by citations
• Social Psychology — 7 citations into it; #8,929 of 15,694 by trust here, #7,832 by citations
• Applied Psychology — 5 citations into it

Whom W. A. Richards trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. R. Piedmont

Who trusts W. A. Richards overall

1. David E. Nichols
2. Matthew W. Johnson
3. Robin L. Carhart-Harris
4. Roland R. Griffiths
5. Katherine A. MacLean

Papers from W. A. Richards's perspective

Ordered by how strongly the researchers W. A. Richards trusts endorse each paper. Same corpus, a different order for every researcher.

1. Human Hallucinogen Research: Guidelines for Safety (Journal of Psychopharmacology)
2. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. (Archives of General Psychiatry)
3. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (Journal of Psychopharmacology)
4. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach
5. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. (Health Psychology)
6. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (Proceedings of the National Academy of Sciences of the United States of America)
7. Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases (Journal of Nervous and Mental Disease)
8. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects (Psychopharmacology)
9. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (Nature Reviews Neuroscience)
10. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (Frontiers in Human Neuroscience)

Their papers

• Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects (2011) — 818 citations
• Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016) — 1,850 citations
• Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008) — 812 citations